Trial intelligence / Profile preview

Melatonin for Statin-Induced Elevated Liver Enzymes

NCT03121521Phase 4Completed

Sponsor
Medical University of Lodz
Start
Sep 2012
Primary completion
Sep 2016
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial in drug induced liver injury (DILI) comparing Melatonin Arm with Placebo Arm (2 arms). Primary endpoints: Aspartate Aminotransferase at 6 months, Alanine Aminotransferase at 6 months and 2 more. Started Sep 2012; status: completed.

02

Drugs

melatonin
03

Conditions

drug induced liver injury (DILI)

Beyond the preview

Go deeper on NCT03121521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03121521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call